Endometrial Carcinoma: A Review of Chemotherapy, Drug Resistance, and the Search for New Agents

Por Moxley, Katherine M., McMeekin, D. Scott
Publicado em 2010

Short-form Ron is a novel determinant of ovarian cancer initiation and progression

Por Moxley, Katherine M., Wang, Luyao, Welm, Alana L., Bieniasz, Magdalena
Publicado no Genes Cancer (2016)

BMI1, a new target of CK2α

Por Banerjee Mustafi, Soumyajit, Chakraborty, Prabir Kumar, Dwivedi, Shailendra Kumar Dhar, Ding, Kai, Moxley, Katherine M., Mukherjee, Priyabrata, Bhattacharya, Resham
Publicado no Mol Cancer (2017)

Tubal Ligation Frequency in Oklahoma Women with Cervical Cancer

Por Mathews, Cara A., Stoner, Julie A., Wentzensen, Nicolas, Moxley, Katherine M., Tenney, Meaghan E., Tuller, Erin R., Myers, Tashanna, Landrum, Lisa M., Lanneau, Grainger, Zuna, Rosemary E., Gold, Michael A., Wang, Sophia S., Walker, Joan L.
Publicado em 2012

A Phase II Evaluation of Pazopanib in the Treatment of Recurrent or Persistent Carcinosarcoma of the Uterus: A Gynecologic Oncology Group Study

Por Campos, Susana M., Brady, William E., Moxley, Katherine M., O'Cearbhaill, Roisin E., Lee, Paula S., DiSilvestro, Paul A., Rotmensch, Jacob, Rose, Peter G., Thaker, Premal H., O'Malley, David M., Hanjani, Parviz, Zuna, Rosemary E., Hensley, Martee L.
Publicado no Gynecol Oncol (2014)